Does OLAPARIB Cause Anaemia? 1,455 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,455 reports of Anaemia have been filed in association with OLAPARIB (Lynparza). This represents 8.0% of all adverse event reports for OLAPARIB.
1,455
Reports of Anaemia with OLAPARIB
8.0%
of all OLAPARIB reports
205
Deaths
469
Hospitalizations
How Dangerous Is Anaemia From OLAPARIB?
Of the 1,455 reports, 205 (14.1%) resulted in death, 469 (32.2%) required hospitalization, and 154 (10.6%) were considered life-threatening.
Is Anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 1,455 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
Myelodysplastic syndrome (466)
What Other Drugs Cause Anaemia?
LENALIDOMIDE (5,322)
CARBOPLATIN (5,312)
RIBAVIRIN (5,130)
ASPIRIN (4,568)
CYCLOPHOSPHAMIDE (4,486)
RITUXIMAB (4,399)
DEXAMETHASONE (4,352)
ADALIMUMAB (3,994)
PACLITAXEL (3,949)
METHOTREXATE (3,913)
Which OLAPARIB Alternatives Have Lower Anaemia Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL